Amanda R Metz,Meghan Barnes,Kevin Andresen,Ginger Stringer,Nicole Comstock,Alexis Burakoff,Shannon R Matzinger,Leslee Warren,Marigny Klaber,Melissa Orozco,Si Ning Chan,Jennifer J Fowler,Shannon L Gearhart,Molly B Nicholson,Rachel Herlihy
Measles is a highly contagious vaccine-preventable viral disease. Successful vaccination programs resulted in limited measles transmission in the United States in 2000, but U.S. cases have been increasing since early 2025. On May 20, 2025, CDC notified the Colorado Department of Public Health and Environment of a measles case in an unvaccinated, non-Colorado resident who had arrived in Denver, Colorado, on an international flight and traveled through the Denver International Airport while infectious. The patient acquired measles in the United States before travelling internationally. Nine secondary measles cases and one tertiary case associated with this traveler were confirmed among Colorado residents; seven additional cases were reported by other jurisdictions. Four of the nine secondary Colorado cases occurred among persons who had received 2 doses of measles, mumps, and rubella vaccine before exposure. Two of these vaccinated persons received negative measles reverse transcription-polymerase chain reaction (RT-PCR) test results from nasopharyngeal swab specimens and positive results from urine specimens. A third patient, with unknown measles vaccination status, received a positive urine RT-PCR test result 24 days after rash onset. Three unvaccinated patients and one with unknown vaccination status were hospitalized, and all recovered. All patients reported having a rash, but vaccinated patients reported fewer and milder symptoms overall. This outbreak highlights the importance of staying up to date with recommended vaccinations, especially before traveling. Routinely collecting urine specimens for measles testing could improve identification of cases and increase detection sensitivity, especially among previously vaccinated persons.
{"title":"Measles Outbreak Associated with an Infectious Traveler - Colorado, May-June 2025.","authors":"Amanda R Metz,Meghan Barnes,Kevin Andresen,Ginger Stringer,Nicole Comstock,Alexis Burakoff,Shannon R Matzinger,Leslee Warren,Marigny Klaber,Melissa Orozco,Si Ning Chan,Jennifer J Fowler,Shannon L Gearhart,Molly B Nicholson,Rachel Herlihy","doi":"10.15585/mmwr.mm7504a1","DOIUrl":"https://doi.org/10.15585/mmwr.mm7504a1","url":null,"abstract":"Measles is a highly contagious vaccine-preventable viral disease. Successful vaccination programs resulted in limited measles transmission in the United States in 2000, but U.S. cases have been increasing since early 2025. On May 20, 2025, CDC notified the Colorado Department of Public Health and Environment of a measles case in an unvaccinated, non-Colorado resident who had arrived in Denver, Colorado, on an international flight and traveled through the Denver International Airport while infectious. The patient acquired measles in the United States before travelling internationally. Nine secondary measles cases and one tertiary case associated with this traveler were confirmed among Colorado residents; seven additional cases were reported by other jurisdictions. Four of the nine secondary Colorado cases occurred among persons who had received 2 doses of measles, mumps, and rubella vaccine before exposure. Two of these vaccinated persons received negative measles reverse transcription-polymerase chain reaction (RT-PCR) test results from nasopharyngeal swab specimens and positive results from urine specimens. A third patient, with unknown measles vaccination status, received a positive urine RT-PCR test result 24 days after rash onset. Three unvaccinated patients and one with unknown vaccination status were hospitalized, and all recovered. All patients reported having a rash, but vaccinated patients reported fewer and milder symptoms overall. This outbreak highlights the importance of staying up to date with recommended vaccinations, especially before traveling. Routinely collecting urine specimens for measles testing could improve identification of cases and increase detection sensitivity, especially among previously vaccinated persons.","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"23 1","pages":"48-54"},"PeriodicalIF":0.0,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146073221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stephanie Spaid Miedema,Sarah A Matthews,Francis B Annor,Andrés Villaveces,Phumzile Mndzebele,Michelle R Adler,Michelle Li,Kelly Ann Gordon Johnson,Denese McFarlane,Paul Rashad Young,Shelly Ann Edwards,Deidra Coy,Caroline Kambona,Elizabeth Washika,António Candeiro,Raquel Cossa de Pinho,Norbert Forster,Peter A Minchella,Rahimisa Kamuingona,Laura F Chiang
Violence is a major cause of morbidity and mortality among young adults in low- and middle-income countries. Men aged 18-24 years (young men) account for the majority of victims and perpetrators of many types of interpersonal violence. Childhood experiences, such as exposure to emotional, physical, or sexual violence or witnessing violence in their homes or communities, might increase risk for perpetration of violence in adulthood. Data from eight Violence Against Children and Youth Surveys conducted in low- and middle-income countries during 2018-2023 were analyzed to assess prevalence of physical and sexual violence perpetration by young men and associations of these events with their exposure to violence during childhood. Lifetime prevalence of physical or sexual violence perpetration among young men was common in all countries and ranged from 12.4% in Eswatini to 44.9% in Côte d'Ivoire. Physical violence victimization or witnessing violence in the household or community before age 18 years was associated with increased odds of violence perpetration among young men in all eight countries after adjusting for demographic covariates and childhood adversity indicators. Efforts to prevent exposure to violence during childhood, a pivotal developmental period, might reduce perpetration of violence by young men and create safer and more secure homes and communities.
{"title":"Prevalence of Violence Perpetration by Men Aged 18-24 Years in Low- and Middle-Income Countries Who Were Exposed to Violence During Childhood - Eight Countries, 2018-2023.","authors":"Stephanie Spaid Miedema,Sarah A Matthews,Francis B Annor,Andrés Villaveces,Phumzile Mndzebele,Michelle R Adler,Michelle Li,Kelly Ann Gordon Johnson,Denese McFarlane,Paul Rashad Young,Shelly Ann Edwards,Deidra Coy,Caroline Kambona,Elizabeth Washika,António Candeiro,Raquel Cossa de Pinho,Norbert Forster,Peter A Minchella,Rahimisa Kamuingona,Laura F Chiang","doi":"10.15585/mmwr.mm7503a2","DOIUrl":"https://doi.org/10.15585/mmwr.mm7503a2","url":null,"abstract":"Violence is a major cause of morbidity and mortality among young adults in low- and middle-income countries. Men aged 18-24 years (young men) account for the majority of victims and perpetrators of many types of interpersonal violence. Childhood experiences, such as exposure to emotional, physical, or sexual violence or witnessing violence in their homes or communities, might increase risk for perpetration of violence in adulthood. Data from eight Violence Against Children and Youth Surveys conducted in low- and middle-income countries during 2018-2023 were analyzed to assess prevalence of physical and sexual violence perpetration by young men and associations of these events with their exposure to violence during childhood. Lifetime prevalence of physical or sexual violence perpetration among young men was common in all countries and ranged from 12.4% in Eswatini to 44.9% in Côte d'Ivoire. Physical violence victimization or witnessing violence in the household or community before age 18 years was associated with increased odds of violence perpetration among young men in all eight countries after adjusting for demographic covariates and childhood adversity indicators. Efforts to prevent exposure to violence during childhood, a pivotal developmental period, might reduce perpetration of violence by young men and create safer and more secure homes and communities.","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"69 1","pages":"41-46"},"PeriodicalIF":0.0,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146021691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carlos Vera-Garcia,Omar Duran-Pena,Manuel Ramirez,Laura Vonnahme,Michelle Sandoval-Rosario,Arnold Vang,Arielle Lasry,Alfonso Rodriguez-Lainz
Patients who have received a diagnosis of tuberculosis (TB) disease face barriers to continuing and completing TB treatment when they relocate between countries, potentially resulting in lower treatment completion rates. Treatment for TB disease can range from 6 months to more than 2 years in duration; failure to complete treatment increases the risk for TB transmission and emergence of drug resistance. CDC's CureTB program makes follow-up TB care referrals for persons relocating to or from the United States, either as temporary visitors or when returning to their home countries, by providing information directly to public health authorities at patients' destinations. To evaluate program performance, public health officials examined 2016-2023 CureTB referral outcomes and treatment completion rates. Among 6,944 referral requests received from U.S. or foreign authorities during 2016-2023, approximately one half (3,912; 56%) were for patients with suspected TB, and approximately one third (2,404; 35%) were for patients with confirmed TB. Among patients who had received a diagnosis of TB for whom a request for a referral was made, CureTB made referrals for 1,741 (72%), including 1,622 (93%) persons relocating to other countries and 119 (7%) relocating to U.S. destinations. Referrals were not required for 522 (22%) persons, and referrals could not be completed for 141 (6%) because information needed to contact the patient was insufficient. Overall, within 12 months of referral, 1,379 (79%) of 1,741 referred patients completed treatment. Among 1,287 (74%) referred patients for whom data on timing of initiation of care were available, treatment completion rates were highest (91%) for 637 patients linked to treatment ≤30 days after departure, followed by 89% for 505 patients linked within 1-3 months, and 85% for 145 linked within 3-12 months. Timely initiation of care can facilitate continuity of care and support completion of TB treatment. CureTB supports the global goals of reducing TB transmission, improving treatment completion rates, and enhancing progress toward TB elimination in the United States; the program can serve as a model for other countries.
{"title":"Continuity of Care for Patients with Tuberculosis Relocating to Other Countries - CureTB Program, 2016-2023.","authors":"Carlos Vera-Garcia,Omar Duran-Pena,Manuel Ramirez,Laura Vonnahme,Michelle Sandoval-Rosario,Arnold Vang,Arielle Lasry,Alfonso Rodriguez-Lainz","doi":"10.15585/mmwr.mm7503a1","DOIUrl":"https://doi.org/10.15585/mmwr.mm7503a1","url":null,"abstract":"Patients who have received a diagnosis of tuberculosis (TB) disease face barriers to continuing and completing TB treatment when they relocate between countries, potentially resulting in lower treatment completion rates. Treatment for TB disease can range from 6 months to more than 2 years in duration; failure to complete treatment increases the risk for TB transmission and emergence of drug resistance. CDC's CureTB program makes follow-up TB care referrals for persons relocating to or from the United States, either as temporary visitors or when returning to their home countries, by providing information directly to public health authorities at patients' destinations. To evaluate program performance, public health officials examined 2016-2023 CureTB referral outcomes and treatment completion rates. Among 6,944 referral requests received from U.S. or foreign authorities during 2016-2023, approximately one half (3,912; 56%) were for patients with suspected TB, and approximately one third (2,404; 35%) were for patients with confirmed TB. Among patients who had received a diagnosis of TB for whom a request for a referral was made, CureTB made referrals for 1,741 (72%), including 1,622 (93%) persons relocating to other countries and 119 (7%) relocating to U.S. destinations. Referrals were not required for 522 (22%) persons, and referrals could not be completed for 141 (6%) because information needed to contact the patient was insufficient. Overall, within 12 months of referral, 1,379 (79%) of 1,741 referred patients completed treatment. Among 1,287 (74%) referred patients for whom data on timing of initiation of care were available, treatment completion rates were highest (91%) for 637 patients linked to treatment ≤30 days after departure, followed by 89% for 505 patients linked within 1-3 months, and 85% for 145 linked within 3-12 months. Timely initiation of care can facilitate continuity of care and support completion of TB treatment. CureTB supports the global goals of reducing TB transmission, improving treatment completion rates, and enhancing progress toward TB elimination in the United States; the program can serve as a model for other countries.","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"54 1","pages":"34-40"},"PeriodicalIF":0.0,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146021637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Grace M Jensen,Cyrus Gidfar,Kirsten Weisbeck,Meghan Barnes,Erin Minnerath,Shannon Matzinger,Allison Wheeler
{"title":"Notes from the Field: Wastewater Surveillance for Measles Virus During a Measles Outbreak - Colorado, August 2025.","authors":"Grace M Jensen,Cyrus Gidfar,Kirsten Weisbeck,Meghan Barnes,Erin Minnerath,Shannon Matzinger,Allison Wheeler","doi":"10.15585/mmwr.mm7502a2","DOIUrl":"https://doi.org/10.15585/mmwr.mm7502a2","url":null,"abstract":"","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"29 1","pages":"20-22"},"PeriodicalIF":0.0,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Malia Ireland,Curtis L Fritz,Stacy Holzbauer,Carrie Klumb,Maria Bye,Leah Bauck,Amanda Bakken,Michelle Dethloff,Rebecca Campagna,Mojgan Deldari,Susan Hepp,Ruth Lopez,Sharon Messenger,Christopher Preas,Aimee Rendon,Stephanie Koch-Kumar,Maria Rangel,Kanwaldeep Bains,Jeffrey Bulawit,Samer Al Saghbini,Trinidad Solis,Joe Prado,John Zweifler,Leticia Berber,Rais Vohra,Ignacio A Santana,Salvador Sandoval,Parmjit Sahota,Mark Hendrickson,Megan Black,Gloria Chavez,Andrew Schwab,Pamela A Yager,Michael Niezgoda,Vaughn V Wicker,Crystal M Gigante,Lillian A Orciari,Jesse D Blanton,Sarah C Bonaparte,Rebecca Earnest,Ryan M Wallace
Rabies is an enzootic viral disease in the continental United States and is typically transmitted through the bite of an infected mammal. Infection is almost always fatal if rabies postexposure prophylaxis (PEP) is not received before the onset of symptoms. Bats are the leading source of U.S. human rabies cases. In 2024, CDC identified two U.S. human rabies deaths in September (Minnesota) and November (California) in persons who had a recognized bat encounter but might not have been aware of the potential rabies risk. Neither patient reported the bat encounter to public health officials nor sought medical attention, including PEP, before symptom onset. Health officials conducted risk assessments among 384 persons in Minnesota, North Dakota, and California who had possible contact with either the bats that were presumed to have rabies or the patients while they were infectious; 45 (12%) of these persons were recommended to receive PEP. Bat bites often result in trivialized or inapparent wounds. Anyone with a possible bat exposure, even in the absence of a recognized bite, should immediately report the encounter to a health care provider or to public health officials for risk assessment, consideration of options for bat testing, and PEP administration, if indicated. Increased awareness of the potential risk for rabies after any bat interaction, even without a visible bite wound, might help prevent deaths.
{"title":"Human Rabies Deaths - Minnesota and California, 2024.","authors":"Malia Ireland,Curtis L Fritz,Stacy Holzbauer,Carrie Klumb,Maria Bye,Leah Bauck,Amanda Bakken,Michelle Dethloff,Rebecca Campagna,Mojgan Deldari,Susan Hepp,Ruth Lopez,Sharon Messenger,Christopher Preas,Aimee Rendon,Stephanie Koch-Kumar,Maria Rangel,Kanwaldeep Bains,Jeffrey Bulawit,Samer Al Saghbini,Trinidad Solis,Joe Prado,John Zweifler,Leticia Berber,Rais Vohra,Ignacio A Santana,Salvador Sandoval,Parmjit Sahota,Mark Hendrickson,Megan Black,Gloria Chavez,Andrew Schwab,Pamela A Yager,Michael Niezgoda,Vaughn V Wicker,Crystal M Gigante,Lillian A Orciari,Jesse D Blanton,Sarah C Bonaparte,Rebecca Earnest,Ryan M Wallace","doi":"10.15585/mmwr.mm7502a4","DOIUrl":"https://doi.org/10.15585/mmwr.mm7502a4","url":null,"abstract":"Rabies is an enzootic viral disease in the continental United States and is typically transmitted through the bite of an infected mammal. Infection is almost always fatal if rabies postexposure prophylaxis (PEP) is not received before the onset of symptoms. Bats are the leading source of U.S. human rabies cases. In 2024, CDC identified two U.S. human rabies deaths in September (Minnesota) and November (California) in persons who had a recognized bat encounter but might not have been aware of the potential rabies risk. Neither patient reported the bat encounter to public health officials nor sought medical attention, including PEP, before symptom onset. Health officials conducted risk assessments among 384 persons in Minnesota, North Dakota, and California who had possible contact with either the bats that were presumed to have rabies or the patients while they were infectious; 45 (12%) of these persons were recommended to receive PEP. Bat bites often result in trivialized or inapparent wounds. Anyone with a possible bat exposure, even in the absence of a recognized bite, should immediately report the encounter to a health care provider or to public health officials for risk assessment, consideration of options for bat testing, and PEP administration, if indicated. Increased awareness of the potential risk for rabies after any bat interaction, even without a visible bite wound, might help prevent deaths.","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"5 1","pages":"28-31"},"PeriodicalIF":0.0,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Notes from the Field: Retrospective Analysis of Wild-Type Measles Virus in Wastewater During a Measles Outbreak - Oregon, March 24-September 22, 2024.","authors":"Rebecca Falender,Melissa Sutton,Paul Cieslak,Juventila Liko,David Mickle,Christine Kelly,Tyler Radniecki","doi":"10.15585/mmwr.mm7502a1","DOIUrl":"https://doi.org/10.15585/mmwr.mm7502a1","url":null,"abstract":"","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"41 1","pages":"16-19"},"PeriodicalIF":0.0,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alexandra Barger,Sara F Margrey,Allison W Siu,Ryan Wallace,Rebecca Earnest,Molly Frankel,Hermella Eshete,Carolyn Swisshelm,Eli Shiltz,Kimberly Wright,Arminda Allen,Lillian A Orciari,Crystal M Gigante,Rene Condori,Pamela Yager,Michael Niezgoda,Panayampalli S Satheshkumar,Douglas Thoroughman,Kathleen Winter,Kelly Giesbrecht
Human rabies cases are rare in the United States; most result from domestic wildlife exposure. U.S. residents can acquire rabies abroad, typically through contact with dogs in areas where dog-maintained rabies is endemic. In November 2024, a man from Haiti was admitted to a Kentucky hospital with an 8-day history of progressive lower extremity pain and weakness. Soon after admission, he experienced hypersalivation, dysphagia, agitation, and eventually, respiratory failure requiring invasive mechanical ventilation. Ten days after admission, he was transferred to a referral hospital in Ohio, where his condition further deteriorated. Despite early consideration of rabies in the differential diagnosis, testing was delayed until late in the clinical course while other diagnostic possibilities were pursued. Rabies testing was initiated on the 29th hospital day and was confirmed 5 days later; the patient died that day. Phylogenetic analysis of the nucleoprotein gene supported acquisition of a dog-maintained rabies virus variant in Haiti. In total, 709 possible contacts during the patient's infectious period underwent risk assessment; 60 (8%) were recommended to receive rabies postexposure prophylaxis (PEP) because of exposure to saliva. Before the patient's rabies diagnosis, standard precautions were used inconsistently during his care; among 60 persons recommended to receive PEP, 52 (88%) were health care workers. Earlier rabies diagnosis and regular adherence to standard infection control precautions, recommended for all patient care, might have reduced health care-associated exposures. This case underscores the importance of early public health consultation upon clinical suspicion of rabies and universal adherence to standard precautions.
{"title":"Imported Human Rabies - Kentucky and Ohio, 2024.","authors":"Alexandra Barger,Sara F Margrey,Allison W Siu,Ryan Wallace,Rebecca Earnest,Molly Frankel,Hermella Eshete,Carolyn Swisshelm,Eli Shiltz,Kimberly Wright,Arminda Allen,Lillian A Orciari,Crystal M Gigante,Rene Condori,Pamela Yager,Michael Niezgoda,Panayampalli S Satheshkumar,Douglas Thoroughman,Kathleen Winter,Kelly Giesbrecht","doi":"10.15585/mmwr.mm7502a3","DOIUrl":"https://doi.org/10.15585/mmwr.mm7502a3","url":null,"abstract":"Human rabies cases are rare in the United States; most result from domestic wildlife exposure. U.S. residents can acquire rabies abroad, typically through contact with dogs in areas where dog-maintained rabies is endemic. In November 2024, a man from Haiti was admitted to a Kentucky hospital with an 8-day history of progressive lower extremity pain and weakness. Soon after admission, he experienced hypersalivation, dysphagia, agitation, and eventually, respiratory failure requiring invasive mechanical ventilation. Ten days after admission, he was transferred to a referral hospital in Ohio, where his condition further deteriorated. Despite early consideration of rabies in the differential diagnosis, testing was delayed until late in the clinical course while other diagnostic possibilities were pursued. Rabies testing was initiated on the 29th hospital day and was confirmed 5 days later; the patient died that day. Phylogenetic analysis of the nucleoprotein gene supported acquisition of a dog-maintained rabies virus variant in Haiti. In total, 709 possible contacts during the patient's infectious period underwent risk assessment; 60 (8%) were recommended to receive rabies postexposure prophylaxis (PEP) because of exposure to saliva. Before the patient's rabies diagnosis, standard precautions were used inconsistently during his care; among 60 persons recommended to receive PEP, 52 (88%) were health care workers. Earlier rabies diagnosis and regular adherence to standard infection control precautions, recommended for all patient care, might have reduced health care-associated exposures. This case underscores the importance of early public health consultation upon clinical suspicion of rabies and universal adherence to standard precautions.","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"177 1","pages":"23-27"},"PeriodicalIF":0.0,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K A Kamanani Conklin,Jasmine Y Nakayama,Miriam E Van Dyke,Kim G Harley,Hannah R Thompson
Physical activity has numerous health benefits, including for women of reproductive age (18-44 years), among whom it can prevent chronic disease, including osteoporosis, and improve maternal health. Understanding the prevalence of leisure-time physical activity among different sociodemographic groups of women of reproductive age can help guide public health interventions and messaging. Data from the 2022 and 2024 National Health Interview Survey were used to examine the prevalences of self-reported leisure-time physical activity and meeting recommendations in the Physical Activity Guidelines for Americans, 2nd edition, among 10,981 women aged 18-44 years by race and ethnicity, age, and educational attainment. Overall, an estimated 25.1% of women aged 18-44 years reported leisure time activity meeting recommendations for both aerobic and muscle-strengthening physical activity, 27.1% reported leisure time activity meeting only the aerobic activity recommendation, and 6.1% reported leisure time activity meeting only the muscle-strengthening activity recommendation. An estimated 47.2% of women reported leisure-time physical activity insufficient to meet either recommendation (including those reporting no leisure time physical activity). Prevalences of reported aerobic and muscle-strengthening physical activity varied by race and ethnicity, age, and educational attainment: higher percentages of younger women (women aged 18-24 years), non-Hispanic White (White) women, and women with higher levels of educational attainment met both recommendations than did older women (women aged 30-34 or 40-44 years), women who are not White, and those with less educational attainment. Given the benefits of physical activity for maternal, physical, and mental health, addressing possible population-specific barriers to physical activity among women of reproductive age could be an important strategy for improving health outcomes.
{"title":"Leisure-Time Physical Activity Among Women of Reproductive Age - United States, 2022 and 2024.","authors":"K A Kamanani Conklin,Jasmine Y Nakayama,Miriam E Van Dyke,Kim G Harley,Hannah R Thompson","doi":"10.15585/mmwr.mm7441a2","DOIUrl":"https://doi.org/10.15585/mmwr.mm7441a2","url":null,"abstract":"Physical activity has numerous health benefits, including for women of reproductive age (18-44 years), among whom it can prevent chronic disease, including osteoporosis, and improve maternal health. Understanding the prevalence of leisure-time physical activity among different sociodemographic groups of women of reproductive age can help guide public health interventions and messaging. Data from the 2022 and 2024 National Health Interview Survey were used to examine the prevalences of self-reported leisure-time physical activity and meeting recommendations in the Physical Activity Guidelines for Americans, 2nd edition, among 10,981 women aged 18-44 years by race and ethnicity, age, and educational attainment. Overall, an estimated 25.1% of women aged 18-44 years reported leisure time activity meeting recommendations for both aerobic and muscle-strengthening physical activity, 27.1% reported leisure time activity meeting only the aerobic activity recommendation, and 6.1% reported leisure time activity meeting only the muscle-strengthening activity recommendation. An estimated 47.2% of women reported leisure-time physical activity insufficient to meet either recommendation (including those reporting no leisure time physical activity). Prevalences of reported aerobic and muscle-strengthening physical activity varied by race and ethnicity, age, and educational attainment: higher percentages of younger women (women aged 18-24 years), non-Hispanic White (White) women, and women with higher levels of educational attainment met both recommendations than did older women (women aged 30-34 or 40-44 years), women who are not White, and those with less educational attainment. Given the benefits of physical activity for maternal, physical, and mental health, addressing possible population-specific barriers to physical activity among women of reproductive age could be an important strategy for improving health outcomes.","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"147 1","pages":"634-639"},"PeriodicalIF":0.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145777303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jacek M Mazurek,Katelynn E Dodd,Girija Syamlal,David J Blackley,David N Weissman
Coal workers' pneumoconiosis (CWP) is a preventable, progressive occupational lung disease caused by inhaling respirable coal mine dust, a complex mixture commonly containing coal, crystalline silica, and other silicate minerals. Early pneumoconiosis can be asymptomatic, but advanced disease often leads to disability and premature death. To describe CWP-associated mortality among U.S. residents aged ≥15 years by industry and occupation, CDC conducted an exploratory analysis of National Vital Statistics System multiple cause-of-death data for 2020-2023, the most recent years that include information on decedents' usual industry and occupation. During 2020-2023, CWP was listed on the death certificate of 1,754 decedents (age-adjusted CWP-associated death rate = 1.3 per 1 million). By industry group, the highest number of CWP-associated deaths occurred among workers in the mining industry (1,255). The highest proportionate mortality ratios (PMRs) were among persons employed in the mining industry (PMR = 50.0) and the construction and extraction occupations (6.2). Among workers employed in the mining industry, the highest PMR was among underground mining machine operators (164.6). The continuing occurrence of CWP-associated deaths underscores the potential value of a comprehensive prevention program (maintaining efforts to control occupational coal mine dust exposures, combined with early disease detection efforts and medical care) and supports potential benefits of ongoing surveillance.
{"title":"Coal Workers' Pneumoconiosis-Associated Deaths - United States, 2020-2023.","authors":"Jacek M Mazurek,Katelynn E Dodd,Girija Syamlal,David J Blackley,David N Weissman","doi":"10.15585/mmwr.mm7441a1","DOIUrl":"https://doi.org/10.15585/mmwr.mm7441a1","url":null,"abstract":"Coal workers' pneumoconiosis (CWP) is a preventable, progressive occupational lung disease caused by inhaling respirable coal mine dust, a complex mixture commonly containing coal, crystalline silica, and other silicate minerals. Early pneumoconiosis can be asymptomatic, but advanced disease often leads to disability and premature death. To describe CWP-associated mortality among U.S. residents aged ≥15 years by industry and occupation, CDC conducted an exploratory analysis of National Vital Statistics System multiple cause-of-death data for 2020-2023, the most recent years that include information on decedents' usual industry and occupation. During 2020-2023, CWP was listed on the death certificate of 1,754 decedents (age-adjusted CWP-associated death rate = 1.3 per 1 million). By industry group, the highest number of CWP-associated deaths occurred among workers in the mining industry (1,255). The highest proportionate mortality ratios (PMRs) were among persons employed in the mining industry (PMR = 50.0) and the construction and extraction occupations (6.2). Among workers employed in the mining industry, the highest PMR was among underground mining machine operators (164.6). The continuing occurrence of CWP-associated deaths underscores the potential value of a comprehensive prevention program (maintaining efforts to control occupational coal mine dust exposures, combined with early disease detection efforts and medical care) and supports potential benefits of ongoing surveillance.","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"155 1","pages":"627-633"},"PeriodicalIF":0.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145777445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：